Incorporating Recommended CVD Prevention Strategies
In Your Patients with Diabetes
By the year 2050, it is estimated that 1 in 3 US individuals will have type 2 diabetes (T2D
), a major risk factor for cardiovascular disease (CVD).
Proven CVD therapies for T2D patients are crucial
to alleviate this chronic disease burden
A new study in the Journal of American College of Cardiology synthesizes evidence-based recommendations for CVD prevention
, focusing on 2 key domains:
1) lifestyle management and 2) CVD risk factor management
. HCPs will benefit from exploring and implementing these current, pragmatic clinical strategies to support patients with diabetes...